Search results
Diabetes/Weight Loss Med Linked to Repeat Spinal Surgery
Medscape· 1 day agoThe diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat...
...Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart...
Digital Journal· 12 hours agoThrough these efforts, Renova has been awarded Innovation Passports for the UK's Innovative Licensing and Access Pathway (ILAP) program by the MHRA for both RT-100 for heart failure (HF) and ...
Don't Overlook Cardiovascular Risk in Type 1 Diabetes
Medscape· 1 day agoCardiovascular disease management is an often overlooked but critical aspect of care for people with...
Low Aspiration Risk in Adults on GLP-1s Undergoing Endoscopy
Medscape· 8 hours agoA retrospective study reported a 0.1% aspiration rate in adults taking GLP-1 receptor agonists and undergoing esophagogastroduodenoscopy, despite a 9.4% rate of retained gastric contents.
Do People With Diabetes Need to Fast Longer Before Surgery?
Medscape· 3 days agoPeople with diabetes don't have higher gastric volumes than those without diabetes after following...
Tandem Recall Urges Updating App Used With Insulin Pump
Medscape· 1 day agoThe recall warns of a software glitch with the t:connect mobile app that can lead to battery failure of the t:slim X2 insulin pump.
Diabetes Insipidus and Hypernatremia: What's the Connection?
Healthline· 6 days agoDiabetes insipidus is a condition characterized by the overproduction of urine. It can lead to a...
iGlarLixi Safe and Effective in Inadequately Controlled T2D
Medscape· 6 days agoA once-daily injectable therapy of a fixed-ratio combination of insulin glargine and lixisenatide...
InterContinental Hotels Group PLC Announces Transaction in Own Shares
Digital Journal· 7 hours ago...Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus Pursuit Church Announces 'United for Israel' Rally at the University of Washington Ecofin Sustainable and Social Impact Term...
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 7 days agoCommercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1 Diabetes expected mid-year ...
